Burning Rock gathers over $125 mln Series C

Burning Rock, a provider of next-generation sequencing diagnostics solutions for precision medicine in oncology, has raised RMB 850 million (over $125 million) in Series C funding. GIC led the round with participation from LYFE Capital, CMB International Capital, Lilly Asia Ventures, Sequoia Capital China and T&Brothers Capital.

14 February 2019•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail